Skip to main content
. Author manuscript; available in PMC: 2022 Nov 19.
Published in final edited form as: ACS Chem Biol. 2021 Sep 27;16(11):2502–2514. doi: 10.1021/acschembio.1c00597

Figure 3.

Figure 3.

Cell killing studies in the breast cancer cell line BT474 (HER2 overexpression) and T47D (HER2 low expression). All assays were performed in triplicate. aRepresentative results of two independent assays. bAverage of two independent assays for the BT474 cell line.